In 1982 Food and Drug Administration approved Humulin, Eli Lily’s recombinant insulin made from Genentech’s specially modified bacteria. It was the first drug produced through recombinant DNA ...
As luck would have it, new developments in biotechnology provided an alternate source for insulin. Recombinant DNA, a lab technique developed in the early 1970s, allowed pharmaceutical manufacturers ...
The development of methods to manipulate DNA opened ... and insulin, both well-studied therapeutics with approved biologic counterparts, were early targeted for recombinant production because ...
Ironically, much further back in history, before the advent of recombinant DNA technology, insulin was extracted from cow pancreases sourced from slaughterhouses. Scientists used a modified virus ...
Then, in 1986, a publication by the Organization for Economic Cooperation and Development (OECD), called "Recombinant DNA Safety Considerations," became the first intergovernmental document to ...